Importance of oral antimetabolite "maintenance" therapy in childhood lymphoblastic leukemia

Pediatr Hematol Oncol. 1996 Sep-Oct;13(5):vii-x. doi: 10.3109/08880019609030848.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Administration, Oral
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / blood
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule*
  • Humans
  • Inactivation, Metabolic
  • Intestinal Absorption
  • Mercaptopurine / administration & dosage
  • Mercaptopurine / blood
  • Mercaptopurine / pharmacokinetics
  • Methotrexate / administration & dosage
  • Methotrexate / blood
  • Methotrexate / pharmacokinetics
  • Patient Compliance* / statistics & numerical data
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / psychology
  • Treatment Failure
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Mercaptopurine
  • Methotrexate